{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021383","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.924310+00:00","generated_at":"2026-06-01T08:32:12.206613+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Protagenic Therapeutics receives Nasdaq deficiency notice for failing minimum equity requirement","bullets":["Company's stockholders' equity fell below Nasdaq's $2.5M minimum as of March 31, 2024.","Must submit a compliance plan by July 8, 2024; Nasdaq may grant up to 180-day extension.","If plan rejected, common stock (PTIX) faces potential delisting; no immediate effect.","Company exploring collaborations and capital raising to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021383","json":"https://secwatch.observer/filing/0001493152-24-021383.json","markdown":"https://secwatch.observer/filing/0001493152-24-021383.md","text":"https://secwatch.observer/filing/0001493152-24-021383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224021383/0001493152-24-021383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224021383/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:32:12.206613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}